Tempus soars 15% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI | TechCrunch

Tempus soars 15% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI | TechCrunch

Tempsa genomic testing and data analysis company started. By Eric LefkowskiThe company that previously founded Groupon, which debuted on the Nasdaq on Friday, rose nearly 15% on the opening day.

The company priced its IPO Thursday at $37 a piece, at the upper end of its $35 to $37 price range, an increase of about $411 million At a completely diluted cost of over $6 billion. Tempus' last public-private valuation was $8.1 billion, however, and the company is valued at $10.25 billion at the end of 2022, according to data from PitchBook.

Despite a substantial discount to its previous valuation, the IPO is a feat for an unprofitable company during what is considered a lean time to launch a public offering. Tempus had revenue of $531 million in 2023 with a net loss of $290 million. But the company's operating losses have narrowed from 83 percent in 2022 to 37 percent in 2023, and Lefkowski told CNBC that he expects Tempus to be cash flow and EBITDA positive in 2025.

Lefkowski founded Tempus in 2015, after noticing that doctors were not relying on data during his wife's breast cancer treatment. He set out to build a company that would use the technology and data obtained from genomic sequencing.

Tempus is now trying to position itself as an AI company, even though AI revenue was only $5.5 million in revenue, roughly 1% of its 2023 revenue. The company said in its prospectus that its AI product line is nascent, but that it plans to “embed AI, including generative AI,” into every aspect of its diagnostic tools.

Lefkovski is by far the largest shareholder in the company. According to S1, he holds 30.1% of the company and 65% of the shareholders' voting power, due to the dual-tier share structure. The firm is controlled by Kimberly Cavill, Brad Kewell's ex-wife, Lefkosfaki Long time business partners, owns a 10.2% stake in Tempus. Scottish asset manager Bailey Gifford owns 5.9% of the company, worth $350 million at the IPO price.

Tempus' initial shareholders include NEA, Revolution and T. Rowe Price. The company raised a $200 million Series G5 from SoftBank in April. Tempus is the fourth company Lefkofsky is taking public. He is best known for founding Groupon, which went public at a cost of About $13 billion in 2011but now trades at less than $600 million.

Tempus is the fourth company Lefkofsky is taking public. He is best known for founding Groupon, which went public at a cost of About $13 billion in 2011but now trades at less than $600 million.

(translation of tags)IPO

About the Author

Leave a Reply